Literature DB >> 6444190

Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis.

C Merck, L Angervall, L G Kindblom, A Odén.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6444190

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand Suppl        ISSN： 0108-0172


× No keyword cloud information.
  42 in total

1.  A case of myxofibrosarcoma of the maxilla with difficulty in preoperative diagnosis.

Authors:  Susumu Nakahara; Hirokazu Uemura; Tomoyuki Kurita; Motoyuki Suzuki; Takashi Fujii; Yasuhiko Tomita; Kunitoshi Yoshino
Journal:  Int J Clin Oncol       Date:  2011-08-10       Impact factor: 3.402

Review 2.  Adult paratesticular myxofibrosarcoma: report of a rare entity and review of the literature.

Authors:  Burak Ozkan; Mustafa Ozgüroğlu; Hamdi Ozkara; Haydar Durak; Zübeyr Talat
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  A Case of Primary Myxoid Malignant Fibrous Histiocytoma of the Pancreas: Clinical, Histopathology, and Immunohistochemistry Findings.

Authors:  Pallav Gupta; Anu Behari; Manoj Jain
Journal:  J Gastrointest Cancer       Date:  2012-09

4.  A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.

Authors:  G Bendix; A Bjelle
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

5.  Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.

Authors:  Ann Y Lee; Narasimhan P Agaram; Li-Xuan Qin; Deborah Kuk; Christina Curtin; Murray F Brennan; Samuel Singer
Journal:  Ann Surg Oncol       Date:  2016-01-12       Impact factor: 5.344

6.  An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI.

Authors:  Kazutaka Kikuta; Daisuke Kubota; Akihiko Yoshida; Hideo Morioka; Yoshiaki Toyama; Hirokazu Chuuman; Akira Kawai
Journal:  Skeletal Radiol       Date:  2014-08-30       Impact factor: 2.199

7.  Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.

Authors:  Fusako Kito; Rieko Oyama; Marimu Sakumoto; Kumiko Shiozawa; Zhiwei Qiao; Shunichi Toki; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  Hum Cell       Date:  2019-02-08       Impact factor: 4.174

8.  Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.

Authors:  Tomoyo Okada; Ann Y Lee; Li-Xuan Qin; Narasimhan Agaram; Takahiro Mimae; Yawei Shen; Rachael O'Connor; Miguel A López-Lago; Amanda Craig; Martin L Miller; Phaedra Agius; Evan Molinelli; Nicholas D Socci; Aimee M Crago; Fumi Shima; Chris Sander; Samuel Singer
Journal:  Cancer Discov       Date:  2016-08-30       Impact factor: 39.397

9.  Primary myxofibrosarcoma of the parotid: case report.

Authors:  Xu Li; Xin Chen; Zhao-Hui Shi; Yang Chen; Jing Ye; Li Qiao; Jian-Hua Qiu
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

10.  Surgical treatment of a giant tibial high-grade mixofibrosarcoma with preservation of limb function: a case report.

Authors:  Domenico Marotta; Marina Angeloni; Marzia Salgarello; Maria Lucia Ricciardella; Byron Chalidis; Giulio Maccauro
Journal:  Int Semin Surg Oncol       Date:  2009-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.